Discovery of an Orally Bioavailable NK1 Receptor Antagonist, (2S,3S)-(2-Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with Potent Antiemetic Activity von Ward, Peter, Armour, Duncan R, Bays, David E, Evans, Brian, Giblin, Gerard M. P, Heron, Nicola, Hubbard, Tania, Liang, Kai, Middlemiss, David

Volltext

Inhibitors of gastric acid secretion von Bays, D E, Finch, H

Volltext

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report von Jacobson, Terry A., MD, Ito, Matthew K., PharmD, Maki, Kevin C., PhD, Orringer, Carl E., MD, Bays, Harold E., MD, Jones, Peter H., MD, McKenney, James M., PharmD, Grundy, Scott M., MD, PhD, Gill, Edward A., MD, Wild, Robert A., MD, PhD, Wilson, Don P., MD, Brown, W. Virgil, MD

Volltext

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary von Jacobson, Terry A., MD, Ito, Matthew K., PharmD, Maki, Kevin C., PhD, Orringer, Carl E., MD, Bays, Harold E., MD, Jones, Peter H., MD, McKenney, James M., PharmD, Grundy, Scott M., MD, PhD, Gill, Edward A., MD, Wild, Robert A., MD, PhD, Wilson, Don P., MD, Brown, W. Virgil, MD

Volltext

“Sick Fat,” Metabolic Disease, and Atherosclerosis von Bays, Harold E., MD

Volltext

Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study) von Ballantyne, Christie M., MD, Bays, Harold E., MD, Kastelein, John J., MD, PhD, Stein, Evan, MD, PhD, Isaacsohn, Jonathan L., MD, Braeckman, Rene A., PhD, Soni, Paresh N., MD, PhD

Volltext

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week stud... von Bays, Harold E., MD, Ballantyne, Christie M., MD, Kastelein, John J., MD, PhD, Isaacsohn, Jonathan L., MD, Braeckman, Rene A., PhD, Soni, Paresh N., MD, PhD

Volltext

Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia von Ballantyne, Christie M., MD, Davidson, Michael H., MD, MacDougall, Diane E., MS, Bays, Harold E., MD, DiCarlo, Lorenzo A., MD, Rosenberg, Noah L., MD, Margulies, Janice, MS, Newton, Roger S., PhD

Volltext

National Lipid Association Annual Summary of Clinical Lipidology 2016 von Bays, Harold E., MD, FNLA, Jones, Peter H., MD, FNLA, Orringer, Carl E., MD, FNLA, Brown, W. Virgil, MD, FNLA, Jacobson, Terry A., MD, FNLA

Volltext

Safety Considerations with Omega-3 Fatty Acid Therapy von Bays, Harold E., MD

Volltext

Adiposopathy, Diabetes Mellitus, and Primary Prevention of Atherosclerotic Coronary Artery Disease: Treating “Sick Fat” Through Improving Fat Function with Antidiabetes Therapies... von Bays, Harold E., MD

Volltext

Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-con... von Davidson, Michael H., MD, Stein, Evan A., MD, PhD, Bays, Harold E., MD, Maki, Kevin C., PhD, Doyle, Ralph T, Shalwitz, Robert A., MD, Ballantyne, Christie M., MD, Ginsberg, Henry N., MD

Volltext

An assessment by the Statin Intolerance Panel: 2014 update von Guyton, John R., MD, FNLA, Bays, Harold E., MD, FNLA, Grundy, Scott M., MD, PhD, FNLA, Jacobson, Terry A., MD, FACP, FNLA

Volltext

Safety Considerations with Niacin Therapy von Guyton, John R., MD, Bays, Harold E., MD

Volltext

Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study von Moriarty, Patrick M., MD, Roth, Eli M., MD, Karns, Adam, MD, Ye, Ping, MD, PhD, Zhao, Shui-Ping, MD, PhD, Liao, Yuhua, MD, Capuzzi, David M., MD, Bays, Harold E., MD, Zhang, Fumin, MD, Liu, Shaowen, MD, Reichman, Alan J., MD, Brusco, Osvaldo A., MD, Lu, Guoping, MD, Lerman, Sam, MD, Duan, Zhenwen, PhD, Guo, Shuren, MD, Liu, Ping Lan, MD, Zhao, Junxian, MD, Zhang, Yan, MD, Li, Simon, MD, PhD

Volltext

National Lipid Association Annual Summary of Clinical Lipidology 2015 von Bays, Harold E., MD, FTOS, FACC, FACE, FNLA, Jones, Peter H., MD, FACP, FNLA, Brown, W. Virgil, MD, FNLA, Jacobson, Terry A., MD, FACP, FNLA

Volltext

Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia von Paolini, John F., MD, PhD, Mitchel, Yale B., MD, Reyes, Robert, BA, Kher, Uma, PhD, Lai, Eseng, MD, PhD, Watson, Douglas J., PhD, MSPH, Norquist, Josephine M., MS, Meehan, Alan G., PhD, Bays, Harold E., MD, Davidson, Michael, MD, Ballantyne, Christie M., MD

Volltext

Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia von Bays, Harold E., MD, Averna, Maurizio, MD, Majul, Claudio, MD, Muller-Wieland, Dirk, MD, De Pellegrin, Annamaria, MD, Giezek, Hilde, MSc, Lee, Raymond, BS, Lowe, Robert S., PhD, Brudi, Philippe, MD, Triscari, Joseph, PhD, Farnier, Michel, MD, PhD

Volltext

Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials) von Mosca, Lori, MD, MPH, PhD, Ballantyne, Christie M., MD, Bays, Harold E., MD, Guyton, John R., MD, Philip, Sephy, RPh, PharmD, Doyle, Ralph T., BA, Juliano, Rebecca A., PhD

Volltext

Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association von Bays, Harold E., MD, FNLA, Toth, Peter P., MD, PhD, FNLA, Kris-Etherton, Penny M., PhD, RD, FNLA, Abate, Nicola, MD, Aronne, Louis J., MD, Brown, W. Virgil, MD, FNLA, Gonzalez-Campoy, J. Michael, MD, PhD, Jones, Steven R., MD, FNLA, Kumar, Rekha, MD, La Forge, Ralph, MSc, FNLA, Samuel, Varman T., MD, PhD

Volltext